Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels.

Autor: Edward A Panacek, John C Marshall, Timothy E Albertson, David H Johnson, Steven Johnson, Rodger D MacArthur, Mark Miller, William T Barchuk, Steven Fischkoff, Martin Kaul, Leah Teoh, Lori Van Meter, Lothar Daum, Stanley Lemeshow, Gregory Hicklin, Christopher Doig
Zdroj: Critical Care Medicine; Nov2004, Vol. 32 Issue 11, p2173-2182, 10p
Databáze: Complementary Index